Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6JANSSEN BIOTECH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

ERDAFITINIB

US Patent Number : 11077106

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3196

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-02-02

blank

02

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

ERDAFITINIB

US Patent Number : 11077106

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3196

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-02-02

blank

03

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

ERDAFITINIB

US Patent Number : 11077106

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3808

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-02-02

blank

04

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

ERDAFITINIB

US Patent Number : 11077106

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3196

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-02-02

blank

05

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

ERDAFITINIB

US Patent Number : 11077106

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3808

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-02-02

blank

06

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

ERDAFITINIB

US Patent Number : 11077106

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3808

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-02-02

blank